Third Rock can­cer start­up Rev­o­lu­tion Med­i­cines scores $100M in fresh raise

Hav­ing swal­lowed fel­low Third Rock-backed Warp Dri­ve Bio’s on­col­o­gy pipeline and wooed Sanofi $SNY on as a part­ner, Red­wood City-based biotech Rev­o­lu­tion Med­i­cines has raised $100 mil­lion in a fresh round of fund­ing.

In 2017, the start­up Rev­o­lu­tion shed its an­ti­fun­gal am­bi­tions and rein­vent­ed it­self as an on­col­o­gy com­pa­ny. And in 2018, the com­pa­ny raised $56 mil­lion in a ven­ture round aimed at mov­ing its first ex­per­i­men­tal ther­a­py in­to the clin­ic.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.